The aromatic amino acids Phe and Tyr are catabolized by a pathway of six enzyme catalyzed reactions. The inherited metabolic diseases phenylketonuria, alkaptonuria, and tyrosinemia types I, II, and III are associated with mutations of these enzymes. Mutations in fumarylacetoacetate hydrolase (FAH 1 ;
EC 3.7.1.2) cause hereditary tyrosinemia type I (HT1), the most severe disease associated with Phe and Tyr catabolism (1) . HT1 is an autosomal recessive disease with an acute form that causes death in infancy due to liver failure and a chronic form that causes an early age death due to hepatocellular carcinoma, liver cirrhosis, and neurologic crises (2, 3) . The lethal nature of HT1 is most likely due to the accumulation of the toxic intermediate fumarylacetoacetate in the absence of FAH activity (4 -6) . This reactive metabolite may cause direct DNA (7) and tissue damage, depletion of cellular glutathione levels (8, 9) , and induction of apoptosis (10) . HT1 is currently treated by combined liver/kidney transplantation (11) and pharmacologic inhibition of hydroxyphenylpyruvate dioxygenase (12) , which catalyzes an earlier step in Phe/Tyr catabolism. A mouse model of HT1 has been developed (5, 14) and can be treated effectively using adenoviral and retroviral based gene therapy vectors to restore FAH activity (14 -16) . These studies have demonstrated that hepatocytes expressing FAH exhibit a strong selective advantage over FAH-deficient cells in vivo. Therefore, it has been suggested that metabolic overloading of the Phe/Tyr catabolic pathway and/or inhibitors of FAH may be of use to improving the efficiency and permanence of liver gene therapy strategies, in general (15) . The overexpression of FAH carried by a gene therapy vector harboring another corrective gene or the expression of inhibitor-resistant variants of FAH could be used as a selectable marker in the treatment of liver diseases other than HT1.
FAH catalyzes the final reaction of Phe/Tyr catabolism, the formation of fumarate and acetoacetate from fumarylacetoacetate hydrolysis (17, Scheme 1). FAH is a homodimer of 46 kDa subunits that catalyzes the hydrolytic cleavage of carboncarbon bonds in a variety of diketo acid substrates (18) . In contrast to common biochemical hydrolysis reactions involving amide and ester bonds, hydrolytic cleavage of relatively stable carbon-carbon bonds is a fairly unusual reaction. Only ten enzymes having this primary function have been described by the Enzyme Commission (EC 3.7.1.1-3.7.1.10). However, FAH is structurally distinct from other carbon-carbon bond hydrolases known to be members of the ␣/␤-hydrolase fold family (19, 20) . In addition to the degradation of aromatic amino acids, carbon-carbon bond hydrolysis reactions are also required for the degradation of aromatic hydrocarbons by soil bacteria (21) . Therefore, further understanding of this type of reaction is of potential use in bioengineering efforts aimed at the bioremediation of toxic hydrocarbon wastes, such as polychlorinated biphenyls.
Crystal structures of FAH and FAH complexed with its physiological products, fumarate and acetoacetate, were recently determined (22) . The FAH structure consists of a 120-residue N-terminal domain of unknown function and a 300-residue C-terminal domain defined by a novel ␤-sandwich roll structure that forms an active site in close proximity to the dimer interface (Fig. 1, A and B) . The FAH active site occurs in a solvent-filled cavity that is complementary in shape and charge to the fumarylacetoacetate substrate (22) . The base of the active site is formed by a metal ion coordinated by four side-chain carboxyl groups at the edge of the ␤-roll, whereas the sides are formed by helices and turns located above the ␤-roll. The product acetoacetate binds to FAH by providing two oxygen ligands to a Ca 2ϩ ion present in the metal ion binding site. Fumarate binding involves an Arg and two Tyr side chains near the entrance to the active site. These structural observations, along with the finding that a D233V substitution causing HT1 (23) and a E201G mutation causing a phenotype like HT1 in mice, 2 led to a proposed mechanism involving the active site His-133 imidazole ring as a general base catalyst in the direct activation of a nucleophilic water molecule (22) . The side chains of Arg-237, Gln-240, and Lys-253 are proposed to stabilize the formation of a tetrahedral alkoxy transition state intermediate, and the metal ion is proposed to function in binding substrate and stabilizing an acetoacetate carbanion leaving group.
Molecules containing phosphorus have proven to be effective inhibitors of enzyme-catalyzed hydrolytic and condensation reactions. Substrate analogs containing phosphonate, phosphonoamidate, and phosphinate groups have been used as effective noncovalent inhibitors of aspartylproteases (24) and metalloproteases (25) , whereas phosphonate and phosphinate bisubstrate inhibitors have been used to inhibit farnesyltransferase (26) . Of particular interest to the enzymatic mechanism of FAH are studies indicating that the tetrahedral geometry associated with the phosphorus groups in these types of inhibitors closely approximates both geometric and electronic aspects of the transition state (24, 27, 28) . Thus, the effectiveness of these compounds as inhibitors is presumably associated with similarities to the high energy reaction intermediates stabilized during catalysis.
The synthesis of an inhibitory phosphinate substrate analog of FAH and its characterization using kinetic and crystallographic methods are reported here. As an effective inhibitor of a carbon-carbon hydrolase, HMPOBA represents the first example of a phosphorus-based analog targeting this class of enzymes. These results provide a context for future structurebased design of FAH inhibitors and provide additional insight into the mechanism by which FAH catalyzes the hydrolysis of carbon-carbon bonds. 
Fumarylacetoacetate Hydrolase Inhibition by Phosphorus-based Inhibitor

EXPERIMENTAL PROCEDURES
Inhibitor Synthesis and Characterization
Products of the synthesis (Scheme 2) were confirmed using gas chromatography/mass spectrometry data acquired on a Hewlett Packard 5995 and by recording 1 H, 13 C, and 31 P NMR data using a Bruker AC-300 (300.13 MHz) spectrophotometer. Solvents were dried by passing over activated alumina, and all reactions were performed under a positive pressure of dry N 2 .
Chloromethyl Methylphosphonate (Product 1)-Oxalyl chloride (6.54 ml, 75.0 mmol) was added dropwise to a stirred solution of dimethyl methylphosphonate (6.2 g, 50.0 mmol) in CH 2 Cl 2 (3 ml) with cooling at 0°C. This reaction was left to warm to room temperature overnight. The volatiles were removed in vacuo to yield a yellow oil, which was suspended in THF (80 ml) and used directly. MS m/z 128.
4-(Methoxyphosphinoyl)-3-oxo-butanoic Acid, 1,1-Dimethylethyl Ester (Product 2)-t-Butyl acetoacetate (17 ml, 102.5 mmol) was added dropwise to a stirred slurry of NaH (2.46 g, 102.5 mmol) in THF (120 ml) with cooling at 0°C. After 10 min the reaction was cooled in a dry ice/acetone bath, whereupon n-BuLi (1.6 M in hexanes, 64.1 ml, 102.5 mmol) was added dropwise. The red-orange reaction was stirred for 40 min. The phosphonochloridate, 1, from above was cooled in a dry ice/ acetone bath, whereupon the red-orange dianion solution was transferred via cannula (dropwise over 15 min) while stirring. After 2 h, the reaction was quenched with HOAc (17.5 ml), water (200 ml) was added, and THF was removed in vacuo. This mixture was extracted with CH 2 Cl 2 (3 ϫ 200 ml), and the organic extract was washed with 250 ml of H 2 O/EDTA (0.01%) and dried in vacuo. Silica gel chromatography (EtOAc/hexane, 1:1) of the rust-colored oil afforded 2 (70% yield). Only data for the keto form are reported. 1 2 Cl 2 (7 ml) and dry cyclopentene (24.5 mmol, 2.2 ml). TMSI (7.83 mmol, 1.11 ml) was added dropwise to the stirred solution at 0°C, and the reaction was left for 2 h. The volatiles were removed in vacuo, and toluene (5 ml) was added and evaporated. The residue was dissolved in THF (2 ml) and transferred via cannula to a stirred solution of KHCO 3 (4.73 mmol, 0.47 g) in water (10 ml). CO 2 was removed under vacuum, and the pH was adjusted to 7 with KOH. Following evaporation in vacuo, residual volatiles were removed by successive evaporation with CH 3 CN (2 ϫ 5 ml) and CCl 4 (5 ml). The residue was dried in vacuo overnight to yield 0.86 g of a pale yellow solid (137%). The solid (0.422 g) was dissolved in H 2 O (5 ml), and the phosphorus concentration (0.2 M) was assayed (29 
Kinetic Assays
Kinetic assays utilized human FAH expressed with an N-terminal poly-His tag using the vector pQE-30 (Qiagen, Chatsworth, CA). Bacteria containing the pQE-FAH plasmid were grown in LB media and induced overnight with 0.5 mM isopropyl ␤-D-thiogalactopyranoside. The bacteria were harvested by centrifugation and lysed by sonication. Lysates were centrifuged, and recombinant FAH was purified from the supernatant using metal chelate chromatography by eluting with a solution containing 50 mM sodium phosphate, pH 6.0, 300 mM NaCl, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride, and 100 mM EDTA. FAH activity was assayed spectrophotometrically using acetopyruvate (AP) (Sigma Chemical Co.) and fumarylacetoacetate (FAA) prepared enzymatically from homogentisic acid (Sigma) as described previously (17, 18, 30) . Assays were initiated by adding recombinant His-tagged FAH to reaction mixtures that covaried AP (0.625, 0.833, 1.25, 2.5, and 5.0 mM) with HMPOBA (0.0, 250, 500, and 750 M) or covaried FAA (3, 8 , and 15 M) with HMPOBA (0, 125, 250, 500, or 750 M). The disappearance of AP and FAA was followed at 292 and 330 nm for 2-3 min at 37°C, respectively. Extinction coefficients of 9,510 and 13,500 cm Ϫ1 M Ϫ1 were used for AP and FAA, respectively. Initial rates were fit to the competitive inhibition model by nonlinear regression analysis using SigmaPlot (Jandell Scientific).
Expression, Crystallization, and Structure Determination
Mouse FAH was expressed as a glutathione S-transferase fusion protein (22) using pGEX4T-1 (Amersham Pharmacia Biotech) and was purified using glutathione-Sepharose (Amersham Pharmacia Biotech). Mouse and human FAH share 88% sequence identity, with strict conservation of the active site residues. The fusion protein was digested using bovine thrombin (Sigma) in 20 mM Tris, 10 mM CaCl 2 , pH 7.4. The free FAH was separated from GST using a Mono-Q column (Amersham Pharmacia Biotech). FAH was at least 90% pure as assessed by Coomassie Blue-stained SDS-polyacrylamide electrophoresis gels and was concentrated using a Centricon ultrafiltration device (Amicon). FAH concentrations were determined using an extinction coefficient of 1.31 ml⅐cm Ϫ1 ⅐mg Ϫ1 at 280 nm. FAH was crystallized by the hanging drop vapor diffusion method at room temperature by combining 10 l of a 3 mg/ml FAH solution with 5 l of a precipitant solution containing 17-18% polyethylene glycol 8000, 0.03-0.15 M nickel acetate, 0.00 -0.24 M sodium acetate, 0.1 M sodium cacodylate, pH 6.5 (22) . Acetate was maintained at a constant 0.3 M concentration. FAH crystallizes under these conditions in the space group P2 1 with unit cell dimensions of 64.1 ϫ 109.5 ϫ 67.5 Å 3 and ␤ ϭ 102.4°. Crystals of FAH were soaked with 0.1 M HMPOBA in precipitant solution for 16 h at room temperature prior to data collection. Data were collected on beamline X12C at the Brookhaven National Laboratory National Synchrotron Light Source at 100 K using a cryoprotectant solution containing 30% polyethylene glycol 400, 0.3 M sodium acetate, 0.1 M sodium cacodylate, pH 6.5. Data were integrated, scaled, and merged using DENZO and SCALEPACK (31) . Details of the data collection and processing are given in Table I below. The structure of FAH complexed with HMPOBA was determined by refining coordinates of the mouse FAH structure (22) against data collected from a single soaked crystal. The positions of the ligand in the FAH active site were apparent in electron density maps calculated using 2F o Ϫ F c and F o Ϫ F c coefficients. Iterative cycles of model building using the program O (32) were followed by restrained refinement using the programs REFMAC (33) and XPLORv3.8 (34) and automated water building using the program ARPP (33) . A model of FAH complexed with HM-POBA consisting of 835 amino acid residues, 1 Ni 2ϩ , 2 Mg 2ϩ , 2 Ca 2ϩ , 2 HMPOBA molecules, 2 acetate molecules, and 833 water molecules has been refined to a crystallographic R-factor of 0.181 (R free ϭ 0.199) at 1.30-Å resolution. Details of the model refinement are given below in Table I . Unrestrained refinement and refinement, including model H atoms did not improve the R free residual. The figures were created using O (32) and MOLSCRIPT (35) .
Supplementary NMR Data
NMR data were obtained using a Bruker AC-300 (300. 
RESULTS
Inhibitor Synthesis and Characterization-HMPOBA was synthesized according to Scheme 2 with a 70% yield via a three-step synthesis from dimethyl methylphosphonate. The phosphonochloridate (product 1) was made by reaction of dimethyl methylphosphonate with oxalyl chloride. Dianions of ␤-keto esters have previously been shown to react with acyl chlorides to form terminally acylated products (36) . Similarly, reaction of this phosphonochloridate with the dianion of t-butyl acetoacetate resulted in phosphinylation of the terminal carbon to yield the phosphinic ester (product 2). Two equivalents of dianion were used in the reaction, because a proton is made acidic upon phosphinylation. Deprotection of the phosphinic ester with TMSI followed by basic work-up circumvented decarboxylation, which occurs in acid, and the di-potassium salt of HMPOBA was produced (product 3).
Kinetic Assays-Hydrolysis of acetopyruvate and the physiological substrate was followed spectrophotometrically by loss of absorbance at 292 and 330 nm, respectively. Initial velocities varied as a function of substrate concentration in the absence of inhibitor according to simple Michaelis-Menten kinetics. Substrate inhibition of FAH by AP (17) was not observed at concentrations 15-fold higher than the K m . Steady-state kinetic assays performed as a function of HMPOBA concentration were fit according to the competitive inhibition pattern. Global fitting of the data measured at three FAA and five inhibitor concentrations yielded a K i of 30.3 Ϯ 7.7 M and a K m of 0.4 Ϯ 0.1 M (data not shown). Global fitting of data measured at five AP and four inhibitor concentrations yielded a K i of 84.8 Ϯ 4.2 M and a K m of 1.3 Ϯ 0.1 mM (Fig. 2) . The K i obtained from AP assays is likely to be more accurate, given difficulties associated with making measurements below the K m of FAA.
Structure of the FAH⅐HMPOBA Complex-The crystal structure of mouse FAH complexed with HMPOBA was determined by soaking an enzyme crystal with the inhibitor. The inhibitor was readily identified in electron density maps calculated at near atomic resolution (1.3 Å) using crystallographic phases from a previously determined structure of mouse FAH (22) and the structure factors measured from the soaked crystal. Crystallographic data and refinement statistics are given in Table I . Refinement of this model against the 1.3-Å data have enabled atomic positions in the model to be defined by electron density that discriminates between carbon, nitrogen, and oxygen atoms ( Fig. 3) with an overall coordinate error estimated at less than 0.05 Å.
The HMPOBA binds the FAH active site through hydrogen bond and/or charge interactions between the pro-S phosphinoyl oxygen atom and the Gln-240 N⑀2, Arg-237 NH1 and Lys-253 N side chain atoms, which are separated by respective distances of 2.9, 2.9, and 2.8 Å from the inhibitor oxygen atom (Fig. 4) . The pro-R phosphinoyl oxygen atom interacts with His-133 at a distance of 2.7 Å and a water molecule at a distance of 2.8 Å bound between the Arg-237 NH 2 and Thr-350 O␥1 atoms (Fig. 4) . HMPOBA provides two ligands to the FAH active site Ca 2ϩ present in the catalytic metal ion binding site through the carbonyl oxygen atom (O8) and one carboxyl oxygen atom (O1). The HMPOBA carboxyl oxygen atoms are also located at 2.9 and 3.0 Å from the main chain nitrogen atom of Thr-350. Although the enzyme ligand interactions appear to be dominated by the electrostatic interactions described above, several complementary van der Waals contacts are also made between the inhibitor and FAH. The methylene carbon bonded to the phosphorus atom is located at respective distances of 3.9 and 4.0 Å from the C␦1 and C␦2 atoms of Leu-247, which originates from the opposite FAH subunit as part of the dimer interface (Fig. 1B) . The inhibitor carbonyl carbon atom is located 3.8 Å from the Tyr-159 C⑀2 atom. The inhibitor methylene carbon atom positioned between the carbonyl and carboxyl groups is located 3.7 Å from the Tyr-128 C␦1 atom and 3.2 Å from the Phe-127 O atom. The HMPOBA methyl carbon atom is located 3.8 Å from the Tyr-128 C⑀1 atom.
Active Site Metal Ions-In addition to the Ca 2ϩ occupying the catalytic metal ion binding site, a second divalent metal ion was identified in the active site during the refinement of the FAH⅐HMPOBA complex when a water molecule bound to the Asp-233 side chain was found to have an abnormally low temperature factor and an associated positive peak in F o Ϫ F c difference maps. The isotropic temperature factors of equivalent water molecules in each active site refined to 3.0 and 3.3 Å 2 , whereas the surrounding oxygen atoms had temperature factors ranging from 8.3 to 9.6 Å 2 . Furthermore, the three carbonyl, one carboxyl, and one hydroxyl oxygen atoms surrounding each of the water molecules provided an excess of hydrogen bond acceptors. Reassignment of this peak to Mg 2ϩ in both active sites eliminated the positive feature from the F o Ϫ F c difference map and resulted in refined temperature factors for the Mg 2ϩ ions of 8.7 Å 2 . Examination of several other FAH structures refined between 1.55 and 1.90 Å (22) indicate similar anomalies with the water bound to the Asp-233 side chain, and in every case reassignment to Mg 2ϩ is consistent with the refined temperature factors and difference maps. Thus, FAH contains a binuclear metal binding site centered about the Asp-233 side chain (Fig. 4) , with one carboxyl oxygen binding the catalytic metal ion and the other binding Mg 2ϩ . The hexagonal coordination geometry for the catalytic metal ion site is best described as a distorted square bipyramid, whereas the pentavalent Mg 2ϩ coordination is best described as a distorted square pyramid. Details of the coordination geometries are given in Table II . The largest distortions of the octahedral Ca 2ϩ coordination involve ligands from the bound inhibitor. These distortions are likely to be due to covalent bonding restraints on the positions of the O1 and O8 atoms within the ␤-keto acid portion of HMPOBA. The O1 and O8 atoms form a six-membered ring with the carbonyl, methylene and carboxyl carbon atoms, and the Ca 2ϩ that is strained by both a 73°O1-Ca 2ϩ -O8 angle and a nearly planar configuration of all but the methylene carbon atom.
Alternate Active Site Side-chain Conformations-FAH crystal structures representing free enzyme, the enzyme⅐HMPOBA complex, and the enzyme⅐product complex reveal distinct sidechain conformations for several catalytic residues within the active site. The CA positions of free FAH, represented by the structure of the selenomethionine-substituted enzyme refined at 1.9 Å, were superimposed with those of the FAH⅐HMPOBA complex with an overall r.m.s. deviation of 0.21 Å, whereas those of the FAH⅐product complex refined at 1.9 Å were superimposed with the FAH⅐HMPOBA structure with an r.m.s. deviation of 0.33 Å. The active site of the free FAH structure and the FAH⅐HMPOBA complex contain an acetate bound to Tyr-128 and Arg-142 (Figs. 3 and 4) , and a second acetate binds the Ca 2ϩ ion in the free FAH structure (22) . The largest side-chain motions in the active site are associated with Tyr-128, Glu-199, Ser-235, Gln-240, and Lys-253. The position of the Glu-199 O⑀2 atom in the HMPOBA complex differs by 2.2 Å relative to both the free and product complex structures (Fig. 5) . This Glu-199 motion is largely the result of respective 20°and 50°rotations about the side-chain 2 and 3 angles in the HMPOBA complex relative to the free and product complex structures. The position of the Ca 2ϩ ligand, Glu-199 O⑀1, does not change significantly between the structures. A 100° 3 rotation changes the position of the Lys-253 N atom by 1.6 Å in the HMPOBA complex relative to the free structure. The Gln-240 side-chain N⑀2 atom also moves about 1.6 and 1.3 Å toward the active site entrance in the product complex relative to the respective free and HMPOBA complex structures. The Tyr-128 OH atom moves by 1.2 Å in the FAH⅐HMPOBA and FAH⅐product complexes relative to that of the free enzyme, but the position of this atom differs by less than 0.3 Å between the structures of the two complexes. The Arg-142 NH 2 and Tyr-244 OH atoms near the entrance to active site also move between 0.7 and 0.9 Å in the complexes relative to the free enzyme. Moderate shifts (0.6 -0.8 Å) in the positions of the Val-137, Arg-237, Pro-246, and Leu-247 side-chain atoms are also observed. In contrast, the main-chain CA atoms of the residues mentioned above deviate by less than 0.4 Å, with the exception of Arg-142, which has CA positional differences of 0.6 and 0.5 Å in the product and HMPOBA complexes relative to the free structure, and Ser-235, having a CA positional difference of 0.5 Å between the HMPOBA and product complex. 
TABLE I
Crystallographic data and refinement The data were integrated and reduced using DENZO and SCALEPACK (31 a I/sigI, ratio of the average intensity to the error of the average intensity.
DISCUSSION
Mechanistic Implications of Phosphorus-based Hydrolase Inhibitors-Our studies of the phosphinoyl compound HMPOBA demonstrate the potential for this class of molecules to effectively inhibit a hydrolase that acts on carbon-carbon bonds. Phosphorus-containing compounds have previously been characterized as noncovalent inhibitors and transition state analogs of other hydrolases, including aspartyl-and metalloproteases (24, 25) . A variety of crystallographic, kinetic, and structure/function data suggests that inhibitors containing tetrahedral phosphorus groups can share characteristics of tetrahedral transition state intermediates (24, 27, 28) . Although the K i for HMPOBA is higher than expected for a true transition state analog, it is reasonable to conclude that our results approximate many of the geometric and electronic features expected for an intermediate of FAH-catalyzed reactions.
The FAH⅐HMPOBA complex shares many features in common with the previously proposed mechanism of FAH (22) . According to this mechanism, substrate binding to the catalytic metal ion positions a carbonyl carbon atom for nucleophilic attack by hydroxide to give rise to a tetrahedral alkoxy intermediate (Fig. 6) . Consistent with this mechanism, the HMPOBA acetoacetyl group interacts directly with Ca 2ϩ present in the catalytic metal binding site, and the tetrahedral phosphinoyl group occupies the position predicted for the alkoxy intermediate (22) . The HMPOBA pro-S oxygen atom is likely to be ionized and accepting three hydrogen bonds from the Arg-237, Gln-240, and Lys-253 side chains (Fig. 4) . These side chains are proposed to function as an oxyanion hole, stabilizing the negative charge acquired at this position during catalysis (Fig. 6) . The pro-R oxygen atom occupies the position of a water molecule hydrogen bonded to the His-133 and Glu-199 side chains (Fig. 5 ) in the free FAH structure (22) . This water molecule is proposed to function as the active site nucleophile (22) as part of a catalytic triad involving the His-133 and Glu-365 side chains (Fig. 4) . Glu-199 may function along with His-133 to direct the nucleophilic attack by orienting the lone pairs of electrons on the water molecule in the direction of the carbonyl carbon atom. Therefore, the FAH⅐HMPOBA structure shares several features of the proposed catalytic intermediate, and provides further support for the involvement of a metal ion and the His-133, Arg-237, Gln-240, and Lys-253 side chains in catalysis. Several features of the FAH⅐HMPOBA structure are likely to account for a relatively high K i . The most significant factor is likely to be the lack of a carboxyethylene group in HMPOBA (Schemes 1 and 2) , which could interact with the charged or polar groups of Tyr-128, Arg-142, and Tyr-244 (Figs. 3-6 ). The importance of these interactions is suggested by the binding of acetate (Figs. 3 and 4) or fumarate at this location in all FAH structures reported to date (22) . Potential van der Waals interactions between the fumaryl group and nonpolar atoms present in the side chains of Tyr-128, Val-137, Phe-141, Tyr-244, and Pro-246 are also absent from the HMPOBA complex. Slight differences in the tetrahedral phosphorus center relative to the predicted alkoxy intermediate (Fig. 6 ) may also exist. The pro-R oxygen atom is likely to be charge neutral and accepting two hydrogen bonds from the protonated imidazole of His-133 and a water molecule (Fig. 4) . This arrangement differs slightly from the proposed tetrahedral intermediate, where the protonated His-133 N⑀2 atom is adjacent to a hydroxyl proton, rather than a ketone oxygen (Fig. 6) . Differences in the atomic radii of tetrahedral C and P could also have slight steric effects. Additional studies are underway to assess these possibilities and to improve inhibitor binding by adding groups to the HMPOBA framework to exploit electrostatic and hydrophobic interactions near the entrance to the active site.
Active Site Metal Ions-The structure of the FAH⅐HMPOBA complex is consistent with both catalytic and structural requirements for divalent metal cations. In addition to substrate binding, the catalytic metal ion is expected to stabilize the enolate form (Fig. 6 ) of the acetoacetate carbanion leaving group (22) . Charge neutralization and prevention of carboxylate side-chain repulsion in this region of the FAH structure are other likely roles for the catalytic metal ion. Ca 2ϩ occupancy of the catalytic metal binding site is consistent with several different FAH structures refined at 1.3-to 1.9-Å resolution. The catalytic metal binding site must have significantly higher affinity for Ca 2ϩ than the crystallization additive Ni 2ϩ ; however, exogenous Ca 2ϩ is added during the FAH purification ("Experimental Procedures"). Studies to identify the physiologically relevant catalytic metal ion are underway.
The Ca 2ϩ coordination geometry (Table II) (13)). This finding further supports the accuracy of the 1.3-Å refinement, which placed no restraints on the metal ion coordination geometries. The significantly longer distance between the HMPOBA carbonyl oxygen (Table II) and Ca 2ϩ may be due to the lack of a formal charge on O8. Although metal⅐carbonyl oxygen complexes were not part of the CSD survey (13) , the distances between Mg 2ϩ and the mainchain carbonyl oxygen atoms (Table II) between Mg 2ϩ and the Asp-233 O␦1 and the Thr-257 O␥ atoms are, respectively, 0.3 and 0.6 Å longer than the mean distance reported for relevant Mg 2ϩ complexes (13) . The newly identified Mg 2ϩ appears to have a role in stabilizing the structure of the ␤-roll that forms the central scaffold of the FAH active site and a possible role in intersubunit communication. In contrast to Ca 2ϩ , Mg 2ϩ is not added exogenously and is not accessible to solvent within the active site. The Mg 2ϩ is located within the ␤-roll structure near the dimer interface, linking main-chain atoms at the end of a helix between Phe-250 and Phe-255 with two ␤-strands between Thr-257 and Ile-259 and between Phe-226 and Ala-236 (Fig. 1) . Mg 2ϩ may also stabilize a loop between Trp-234 and Lys-253 that positions Pro-246 and Leu-247 within the active site of the opposite subunit. Although half-site reactivity or catalytic cooperativity has not been reported, the FAH structure seems suited to such functions. Interactions between the Leu-247 side chain of one subunit and HMPOBA bound in the opposite subunit were described above. Pro-246 also makes an intersubunit interaction with Tyr-244 of the fumaryl binding site and interacts with fumarate in the FAH⅐product complex (22) . Therefore, changes within the fumaryl and/or acetoacetyl binding sites could be transmitted through the 234/253 loop to the active site in the opposite subunit. The catalytic residues Arg-237, Gln-240, and Lys-253 and the D233V, W234G, and P249T mutations causing HT1 (19) also occur in this region of the structure. Therefore, Mg 2ϩ appears to be important for joining secondary structures within the ␤-roll, as well as having potential roles in communication between active sites and positioning the side chains of the oxyanion hole. Mg 2ϩ could have additional catalytic effects. Mg 2ϩ could maintain a favorable overall charge within the active site by balancing the formal negative charges associated with the dicarboxylic acid substrate and the four carboxylate ligands to the catalytic metal ion. Assuming Arg-142, Arg-237, and Lys-273 are protonated, the net formal charge of the substratebound active site in the presence of two divalent cations is ϩ1. Finally, Mg 2ϩ could affect properties of the catalytic metal ion, such as Lewis acidity, through the shared Asp-233 carboxylate ligand. The importance of this residue in normal FAH function is indicated by the HT1-associated D233V mutation (23) , which is anticipated to affect both the catalytic metal ion and Mg 2ϩ binding sites.
Side-chain Mobility-A comparison of FAH structures bound to different ligands indicates conformational mobility within the FAH active site. Four of the five active site residues having the largest positional differences also have central roles in the proposed mechanism. This observation suggests that these conformational differences may be significant to substrate binding or product release, formation of the leaving group, and proton transfer to the leaving group. The observed positional deviations are significantly larger than the estimated coordinate errors of the refined structures and involve side chains that are well defined by electron density. Indeed, these side chains have temperature factors that are less than 24.0 Å 2 , indicating they occupy distinct, stable conformations in different structures, rather than being mobile within a given structure.
Entry to the FAH active site appears restricted in the FAH structures, indicating that a conformational change is required for substrate binding. A small opening to the active site is defined by a triangular arrangement of the Arg-142 NH1, Pro-246 C␤, and Tyr-244 OH atoms separated by distances of 5.3-5.5 Å. Considering the van der Waals radii of the atoms, this opening is not large enough to accept substrates, products, or inhibitors. However, ligand binding to FAH within the crystal lattice suggests the entrance to the active site does open.
The entrance to the active site is likely to occur near the end of a helix formed between Ser-130 and Gly-143. This region has some of the highest temperature factors found in the FAH structures and shows some of the largest r.m.s. deviations between main-chain positions. Furthermore, a G369V mutation causing HT1 is located adjacent to this region (23) . A transient opening of Phe-141 and Arg-142 away from the active site would expose an elongated entrance. Conversely, occupancy of the fumarate binding site would cause the active site to close by creating the hydrogen bond network between Tyr-128, Arg-142, and Tyr-144. It is also interesting to note that, although fumarate binding might be expected to affect the conformation of residues near the entrance to the active site, HMPOBA binding also resulted in significant conformational changes in Tyr-128, Arg-142, and Tyr-244 relative to the free structure. Therefore, ligand occupancy of the acetoacetate binding site can apparently induce conformational changes near the entrance to the active site.
Conformational changes affecting the oxyanion hole may accompany the transformation of the tetrahedral alkoxy intermediate to the planar fumarate carboxyl group (Fig. 6 ). Substantial differences in the Arg-237, Gln-240, and Lys-253 sidechain positions are observed between the different FAH structures. The separation of products following the breakdown of the tetrahedral intermediate may be indicated in comparing the HMPOBA and product structures, which reveals a 2.3-Å difference between the positions of the HMPOBA phosphorus and the fumarate carboxyl carbon atoms. Thus, fumarate formation may pull Gln-240 in the direction of the entrance to the active site.
Side-chain mobility may also be related to proton transfer to the carbanion leaving group. This step may involve the protonated forms of either the fumarate carboxyl group or the Lys-253 amine group. His-133 is unlikely to serve as the general acid, because the N⑀2 atom is located over 5.1 Å away from the HMPOBA equivalent of the acetoacetate methyl group, the C9 atom. The superimposed structures reveal that a fumarate carboxyl oxygen is located 2.9 Å from the HMPOBA C9 atom. This distance would allow for direct or water-mediated proton transfer between the protonated carboxyl and the leaving carbanion. Another possibility involves the Lys-253 rotation away from an interaction with the Ser-235 O␥ in the free structure to interact with HMPOBA as part of the oxyanion hole. This motion may be coupled with a change in the conformation of Glu-199, which pivots about the catalytic metal ion to accept a hydrogen bond from Lys-253 in the HMPOBA structure (Fig. 5) and suggests Lys-253 could function as the proton donor. Indeed, a preferred rotamer conformation resulting from a 90°r otation about the side chain 2 angle brings the Lys-253 N atom within 3.0 Å of the HMPOBA C9 atom.
Summary-Studies of more exact transition state analogs, currently under development in our laboratories, are expected to address many of these issues. In particular, a crystal structure of FAH complexed with an analog, which incorporates a competent mimic of the fumaryl portion of FAA should allow us to probe the role of the 140/147 loop in the closing/opening portion of the active site and to ascertain the related functions of Phe-141 and Arg-142 in covering the respective binding sites of acetoacetate and fumarate. Additionally, it is expected that such an analog will serve as a more potent inhibitor of FAH, with profound therapeutic properties for hepatic repopulation, far superior to that observed with HMPOBA.
